This week’s excitement surrounding the groundbreaking U.S. Food and Drug Administration (FDA) approval of the CAR T–cell therapy tisagenlecleucel...
Yesterday marked a much anticipated milestone for the oncology community: The U.S. Food and Drug Administration (FDA) announced the...
This week, the U.S. Food and Drug Administration (FDA) added two new treatments to the armamentarium for hematologic oncologists...
Earlier this week, the U.S. Food and Drug Administration (FDA) approved a new molecularly targeted therapeutic called neratinib (Nerlynx)...
Hot on the heels of the FDA’s landmark approval of an anticancer therapeutic for use based on whether a...
Tuesday marked a milestone for the oncology community: The U.S. Food and Drug Administration (FDA) announced its first approval...
At the end of last week, the U.S. Food and Drug Administration (FDA) approved expanding the use of pembrolizumab...
This time last year there were no immune checkpoint inhibitors approved by the U.S. Food and Drug Administration (FDA)...
Last week, a flurry of U.S. Food and Drug Administration (FDA) oncology approvals concluded with the approval of the...
Earlier this week, the U.S. Food and Drug Administration (FDA) announced that it had approved a new immune checkpoint...